Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

BACKGROUND: In 2009 the declaration by the World Health Organization of a global pandemic of influenza-H1N1 virus led to a vaccination campaign to ensure protection for immunocompromised patients. The goal of this study was to determine the efficacy of the 2009 H1N1 vaccine in patients with hematolo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: de Lavallade, Hugues, Garland, Paula, Sekine, Takuya, Hoschler, Katja, Marin, David, Stringaris, Kate, Loucaides, Eva, Howe, Katherine, Szydlo, Richard, Kanfer, Ed, Macdonald, Donald, Kelleher, Peter, Cooper, Nichola, Khoder, Ahmad, Gabriel, Ian H., Milojkovic, Dragana, Pavlu, Jiri, Goldman, John M., Apperley, Jane F., Rezvani, Katayoun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ferrata Storti Foundation 2011
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031700/
https://ncbi.nlm.nih.gov/pubmed/20971824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.032664
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items